Drugs / APL-10456-Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07399132 | Feb 2026 → May 2027 expected | viral respiratory tract infection | Apollo Therapeutics Ltd | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | APL-10456-Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07399132 ↗ |
| Modality | Vaccine | “APL-10456-Vaccine, a Rhinovirus (RV) Vaccine” NCT07399132 ↗ |